Pathophysiology and treatment of chronic thromboembolic pulmonary hypertension

HIGHLIGHTS

  • who: Naoyuki Otani and collaborators from the Department of Cardiology, Dokkyo Medical University Nikkyo Medical Center, Nikko, Japan have published the research work: Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension, in the Journal: (JOURNAL)
  • what: This review discusses the complex pathogenesis of CTEPH and presents the standard of care PEA as well as a new device called BPA which is showing remarkable progress in efficacy and safety.
  • future: The molecular processes underlying 2 of 20 microvasculopathy are not fully understood and further research is needed.

SUMMARY

    Chronic thromboembolic . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?